You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › April › 30
Lilly
89 days ago
Eli Lilly entered Thursday well off its highs. A blowout quarter shows the market got this one wrong.
FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies ○
If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines unless they appear on the FDA's drug shortage list.
More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says ○
found
Eli Lilly's weight loss pill launch has been closely watched after the successful start of Novo Nordisk's Wegovy pill.
90 days ago
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket ⊕
Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.
page 1 of 1